—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
中草药(英文版)(Chinese Herbal Medicines)
CN外文 - 季刊
  • 中草药(英文版)(Chinese Herbal Medicines)
  • 复合影响因子:2.06
  • CSCD(2025-2026)科技核心(2025学术卷)
  • 知网,万方目次,维普目次
  • /有基金 100.0%
  投稿方式:官网投稿
  • 栏目频次
  • 一作占比
  • 单位占比
  • 热词

高频栏目

100%期平均发文量1篇
100%期平均发文量11篇

中频栏目

66.7%期平均发文量5篇

低频栏目

16.7%期平均发文量1篇
16.7%期平均发文量6篇
16.7%期平均发文量6篇
16.7%期平均发文量4篇
16.7%期平均发文量4篇
16.7%期平均发文量4篇
16.7%期平均发文量1篇
16.7%期平均发文量4篇
16.7%期平均发文量5篇
16.7%期平均发文量3篇
100.0%
暂无单位信息.
暂无关键词信息.
  • 更多

    期刊简介

  • 《中草药(英文版)》(ChineseHerbalMedicines)(季刊)创刊于2009年,由天津药物研究院主管,天津药物研究院、中国医学科学院药用植物研究所主办,其中天津药物研究院为主要主办单位。办刊宗旨及业务范围为:继承和发扬祖国医药学遗产,报道和反映中草药研究最新进展,宣扬我国中草药传统特色,加强与世界各国传统药物研究的经验交流,在中医与西医、传统与现代、东方与西方之间架起一座理解好沟通的桥梁,促进中药现代化、国际化。主要栏目:临床论著、实验研究、经验交流、学术动态、研究进展、人物介绍、实用验方、综述。

  • 基本信息

  • 期刊名称:中草药(英文版)(Chinese Herbal Medicines)
  • 主管单位:天津药物研究院
  • 主办单位:天津药物研究院;中国医学科学院药用植物研究所
  • 国内刊号:CN 12-1410/R
  • 国际刊号:ISSN 1674-6384
  • 出刊日期:
    期刊定价:
  • 邮发代码:
  • 所在省区:天津
    邮政编码:
  • 联系地址:

  • 投稿信息

  • 学科分类:中国医学
    版面费用:待核实
  • 字数要求:4000-30000
    查重要求:-
  • 复合因子:2.06
    综合因子:1.634
  • 审  稿 费:待核实
    稿费:待核实
  • 本刊可发:
  • 特殊属性:第一批认定学术期刊

  • 联系方式

  • 投稿网址:https://mc03.manuscriptcentral.com/chm
  • 官网网址:http://www.tiprpress.com/chmen/ch/index.aspx
  • 电话传真:022-23006901(202401期);010-57833035(官网电话)
  • 电子邮箱:见投稿指南处
  • 微信公众号:

审稿时间:暂无参考数据,审稿时间不确定!

投稿难度:网友分享,仅供参考

见刊周期:-

温馨提示以上只是参考信息,实际情况会根据投稿主题、稿件质量和数量、审稿流程有所差异。想获得更准确信息请联系期刊的编辑部进行咨询。

欢迎点评!让信息更透明,使投稿更轻松!
    • 审稿时间:
      是否录用:
    • 发表排期:
      查重要求:
    • 有无课题:
      有无回复:
    • 我的学历:
      我的职称:
    • 审稿费用:
      版面费用:
    • 稿       费:
      稿件字数:
    • 投稿难度:
    • 该刊可发:
    • 投稿主题:
匿名: 验证码: 点击切换验证码

    • 1、投稿方式:在线投稿。

      2、刊内网址:(202401期)

      http://www.tiprpress.com

      http://www.sciencedirect.com/journal/chinese-herbal-medicines

      http://www.tiprpress.com/chmen/ch/index.aspx

      http://www.elsevier.com/locate/chmed

      https://mc03.manuscriptcentral.com/chm(投稿系统)

      3、出刊日期:季刊,逢季首月18日出版。

      2024年4月17日星期三

      《中草药(英文版)》作者须知Instruction for Authors

      【官网信息】

      Chinese Herbal Medicines (CHM) is an official international journal sponsored by Tianjin Institute of Pharmaceutical Research and Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences. The purpose of CHM is to provide a forum for the studies on Chinese herbal medicines, phytomedicines, and natural products as well. The journal will accept the following contributions: letters, original articles, review papers, short communications, book reviews, conference announcements, information, etc. The journal involves the studies on active ingredients and complex formulations of herbal medicines in medicinal resource, phytochemistry, pharmacology, toxicology, pharmacokinetics, and therapeutic function by experiment and clinical trials. It is the interest of this journal to introduce the latest development in pharmaceutical sciences to readers.

      The journal is included in the following databases: ESCI, PubMed Central, Scopus, DOAJ, CAB ABSTRACTS, CAS, EMBASE, IC, UPD, Global Health, etc. Since 2013, CHM has been selected as one of the Chinese Core Periodicals of Science and Technology for nine consecutive years. In 2019, CHM was successfully selected by China Association for Science and Technology for the China Science and Technology Journal Excellence Action Plan. The journal has been awarded the distinction of Excellent International Impact Academic Journals of China in 2016, 2019, 2020, 2021 and 2022.

      1. Submission of manuscripts

      Authors could submit their manuscripts through online submission http://mc03.manuscriptcentral.com/chm. The following should be complied with: size of character 12 point, double-spaced, consecutive numbering of the lines and pages. The text should be in Word document for Windows.

      2. Structure of manuscripts

      2.1  Title

      Please provide a title that is concise, informative, and relevant, ideally it should contain no more than 30 words.

      2.2  Authors and affiliation

      Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Capitalize the first letter in the surname(s) and spell out the given name(s) in full-name form. The corresponding author should be indicated by an asterisk (*) to the right of the name and the e-mail address given in the footnote. The affiliation of each author should be provided, including complete address information (city, zip code, and country). Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address.

      Any change in authorship must be approved in writing by all authors. Authors who have contributed equally should be marked with a superscript symbol (1). The following statement added in the footnote: “These authors contributed equally to this work”. The equal roles of authors should also be adequately disclosed in the authors’ contributions statement.

      2.3  Abstract

      The paper should contain an abstract with 200–300 words in English. The abstract should summarize the main points of the article. The structure form of the abstract should consist of Objective (purpose of the study), Methods (basic procedures), Results (final findings with main data), and Conclusion (potential possibility on the result).

      ……

      更多详情:

      https://www.tiprpress.com/chmen/site/menu/20100204181305001




    验证码: 点击切换验证码